Comparison of endoscopic-guided vs. electromyographyguided Botulinum toxin injection treatments in adductor spasmodic dysphonia
Keywords:
Adductor spasmodic dysphonia, botulinum toxin, electromyography, vocal injectionAbstract
Background: Electromyography (EMG)-guided botulinum injection is recommended in clinical practice guideline for spasmodic dysphonia. However, other alternative techniques have been practiced in absence of EMG machine. Comparison of the techniques is limited in the literatures.
Objectives: This study aimed to compare the effectiveness of treatment between the EMG-guided technique and the endoscopic-guided technique in adductor spasmodic dysphonia.
Methods: Five patients who were diagnosed with adductor spasmodic dysphonia (AdSD) were enrolled and then randomized into two groups. Patient data (before and after treatment) were collected. The outcome measurement included voice analysis, voice handicap index (VHI), duration aspiration, duration of breathiness, mean effective duration, and satisfaction score (visual analog scale). The difference between the pretreatment data and the posttreatment data at 1 and 3 months was compared.
Results: The mean effective duration between of the EMG group and the endoscopic group was not significantly different. There were no significant differences in voice analysis differences in the EMG group and the endoscopic group after botulinum toxin injection 1 month and 3 months after treatment. There were no significant differences in adverse effects between the two groups in both durations of breathiness and duration of aspiration. No significant difference in satistactions score among two groups was observed.
Conclusion: Botulinum toxin injection under endoscopic guidance is a feasible technique for the treatment of adductor spasmodic dysphonia in the context of lack of EMG equipment. Additionally, endoscopic guidance is a simple and inexpensive device, composed of materials at hand in every otolaryngology unit. However, we suggest that the optimal injection technique would be determined by surgeon training, equipment availability, and preferences.
Downloads
References
Cannito MP, Johnson JP. Spastic dysphonia: a continuum disorder. J Commun Disord 1981;14:215-33.
https://doi.org/10.1016/0021-9924(81)90037-X
Blitzer A, Brin MF. Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol 1991;100:85-9.
https://doi.org/10.1177/000348949110000201
Hyodo M, Hisa Y, Nishizawa N, Omori K, Shiromoto O, Yumoto E, et al. The prevalence and clinical features of spasmodic dysphonia: A review of epidemiological surveys conducted in Japan. Auris Nasus Larynx 2021;48:179-84.
https://doi.org/10.1016/j.anl.2020.08.013
Stachler RJ, Francis DO, Schwartz SR, Damask CC, Digoy GP, Krouse HJ, et al. Clinical practice guideline: hoarseness (dysphonia) (update). Otolaryngol Head Neck Surg 2018;158 1 suppl:S1-S42.
https://doi.org/10.1177/0194599817751030
Bielamowicz S, Squire S, Bidus K, Ludlow CL. Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 2001;110: 406-12.
https://doi.org/10.1177/000348940111000503
Adams SG, Hunt EJ, Charles DA, Lang AE. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results. J Otolaryngol 1993;22:171-5.
Sulica L. Contemporary management of spasmodic dysphonia. Curr Opin Otolaryngol Head Neck Surg 2004;12:543-8.
https://doi.org/10.1097/01.moo.0000145959.50513.5e
Ford CN, Bless DM, Lowery JD. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia. Otolaryngol Head Neck Surg 1990; 103:752-8.
https://doi.org/10.1177/019459989010300515
Green DC, Berke GS, Ward PH, Gerratt BR. Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia. Ann Otol Rhinol Laryngol 1992;101:883-7.
https://doi.org/10.1177/000348949210101101
Jaruchinda P, Suwanwarangkool T. Cross-cultural adaptation and validation of the voice handicap index into Thai. J Med Assoc Thai Chotmaihet thangphaet 2015;98:1199-208.
Boone DR. Voice therapy for hyperfunctional voice problems. Trans Pac Coast Otoophthalmol Soc Annu Meet 1969;50:323-8.
Stemple JC, Lee L, D'Amico B, Pickup B. Efficacy of vocal function exercises as a method of improving voice production. J Voice 1994;8:271-8.
https://doi.org/10.1016/S0892-1997(05)80299-1
Dedo HH, Izdebski K. Intermediate results of 306 recurrent laryngeal nerve sections for spastic dysphonia. Laryngoscope 1983;93:9-16.
https://doi.org/10.1288/00005537-198301000-00002
Langeveld TP, van Rossum M, Houtman EH, Zwinderman AH, Briaire JJ, Baatenburg de Jong RJ. Evaluation of voice quality in adductor spasmodic dysphonia before and after botulinum toxin treatment. Ann Otol Rhinol Laryngol 2001;110:627-34.
https://doi.org/10.1177/000348940111000707
Woo SH, Son Y-I, Lee SH, Park JJ, Kim Jp. comparative analysis on the efficiency of the injection laryngoplasty technique using calcium hydroxyapatite (CaHA): the thyrohyoid approach versus the cricothyroid approach. J Voice 2013;27:236-41
https://doi.org/10.1016/j.jvoice.2012.11.001
Clary MS, Milam BM, Courey MS. Office-based vocal fold injection with the laryngeal introducer technique. Laryngoscope 2014;124:2114-7.
https://doi.org/10.1002/lary.24659
Dharia I, Bielamowicz S. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia in a large cohort. Laryngoscope 2020;130:2659-62.
https://doi.org/10.1002/lary.28457
Elmiyeh B, Prasad VM, Upile T, Saunders N, Youl BD, Epstein R, et al. A single-centre retrospective review of unilateral and bilateral dysport injections in adductor spasmodic dysphonia. Logoped Phoniatr Vocol 2010;35:39-44.
https://doi.org/10.3109/14015431003604804
Kim JW, Park JH, Park KN, Lee SW. Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: a prospective comparative study. Scienitific World Journal 2014;2014:327928.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Chulalongkorn Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
